Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Nuclear Shape Changes Are Induced by Knockdown of the SWI/SNF ATPase BRG1 and Are Independent of Cytoskeletal Connections

  • Karen M. Imbalzano,

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  • Nathalie Cohet,

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  • Qiong Wu,

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  • Jean M. Underwood,

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  • Anthony N. Imbalzano,

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  • Jeffrey A. Nickerson

    Affiliation Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

Abstract

Changes in nuclear morphology occur during normal development and have been observed during the progression of several diseases. The shape of a nucleus is governed by the balance of forces exerted by nuclear-cytoskeletal contacts and internal forces created by the structure of the chromatin and nuclear envelope. However, factors that regulate the balance of these forces and determine nuclear shape are poorly understood. The SWI/SNF chromatin remodeling enzyme ATPase, BRG1, has been shown to contribute to the regulation of overall cell size and shape. Here we document that immortalized mammary epithelial cells show BRG1-dependent nuclear shape changes. Specifically, knockdown of BRG1 induced grooves in the nuclear periphery that could be documented by cytological and ultrastructural methods. To test the hypothesis that the observed changes in nuclear morphology resulted from altered tension exerted by the cytoskeleton, we disrupted the major cytoskeletal networks and quantified the frequency of BRG1-dependent changes in nuclear morphology. The results demonstrated that disruption of cytoskeletal networks did not change the frequency of BRG1-induced nuclear shape changes. These findings suggest that BRG1 mediates control of nuclear shape by internal nuclear mechanisms that likely control chromatin dynamics.

Introduction

The SWI/SNF complexes comprise a family of ATP-dependent chromatin remodeling enzymes that utilize the energy released from ATP hydrolysis to break or destabilize histone-DNA contacts on the nucleosome [1],[2]. Numerous structural alterations are possible following SWI/SNF mediated remodeling [3],[4]. The functional consequence of these chromatin structure changes is increased accessibility of regulatory and enzymatic proteins that modulate chromatin assembly, DNA replication, repair and recombination, and transcription [3]. SWI/SNF complexes are evolutionarily conserved in eukaryotes and contain either BRM (Brahma) or BRG1 (Brahma-related gene 1) as an essential ATPase subunit [5][7]. SWI/SNF complexes include other proteins known as BRG1 and BRM-associated factors (BAFs) that can modulate the activity of BRM or BRG1 in a gene-specific fashion [7].

To address the function of the SWI/SNF ATPases in normal mammary epithelial cells, we generated inducible knockdowns of either BRG1 or BRM in the non-tumorigenic mammary epithelial cell MCF-10A [8]. The depletion of either ATPase subunit decreased the rate of cell proliferation without inducing either apoptosis or complete growth arrest in monolayer culture or in three-dimensional reconstituted basement membrane (rBM) cultures. The length of the cell cycle increased after depletion of either SWI/SNF ATPase, indicating a role for BRG1 and BRM as positive regulators of proliferation at all stages of the cell cycle. These results were unexpected since mice heterozygous for the BRG1 gene have an increased risk of mammary carcinoma [9][11].

We report here that the depletion of BRG1, but not of BRM in immortalized but non-transformed mammary epithelial cells induced nuclear shape changes, including lobulation and the development of folds in the nuclear surface. Paradoxically, these changes in nuclear shape were similar to changes in nuclear structure often observed in tumors [12], including breast tumors [13],[14]. Similar changes have also been observed in the laminopathies, diseases caused by the mutation of Lamin A or its interacting structural proteins at the nuclear periphery [15],[16]. Exploration of these diseases has demonstrated the critical importance of the architecture of the nuclear periphery, the place where the nuclear lamina, nuclear envelope, nuclear lamina-associated chromatin, and the cytoskeleton all intersect. Disruption of these structures may have profound effects on cellular mechanics and on gene expression. Multiple proteins of the nuclear lamina and nuclear envelope bind to chromatin (reviewed in [17]). The genes packaged in the peripheral heterochromatin attached to the nuclear lamina are predominantly silenced; release of chromatin from the lamina toward the nuclear interior may facilitate the activation of such genes [17].

Nuclear shape may be determined in part by connections between the peripheral structures of the nucleus and the cytoskeleton. Forces generated by the cytoskeleton would keep the nucleus under tension at each connection, and the balance of tensions would influence nuclear shape. The continuity between cell surface integrins, the cytoskeleton, and the nucleus was directly demonstrated in living endothelial cells by micromanipulation [18]. The nucleus in differentiated cells is under tension mediated by a pre-stressed cytoskeleton [19],[20]. Early studies showed that the intermediate filaments were connected to the nucleus in epithelial cells where they are heteropolymers of at least two cytokeratins [21][24], in fibroblasts where they are polymers of vimentin [22],[25], and in a subset of neurons that have intermediate filaments containing peripherin [26]. Electron microscopy revealed filaments of 5 to 6 nm in diameter connecting 10 nm cytokeratin filaments to the nuclear lamina [27]. Nuclear-anchored cytokeratin filaments attach to desmosomes and to other structures at the plasma membrane, linking the nucleus through the intermediate filaments to the cell surface [22],[24].

More recent work characterizing the molecular details of these connections has identified the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex [28],[29]. In this complex, the Nesprin proteins located at the nuclear envelope bind to cytoskeletal filaments, cross the outer nuclear membrane, and bind the SUN1 and SUN2 proteins in the lumen of the nuclear envelope. The SUN proteins, which form a heterodimer, bind to lamins in the nuclear lamina, to other proteins associated with the nuclear lamina and inner nuclear membrane, and to the chromatin that is located at the inner surface of the nuclear lamina. Different members of the Nesprin protein family bind to actin filaments of the cytoskeleton (Nesprin 1 and 2) [30],[31], to plectin cross-bridges with intermediate filaments (Nesprin 3) [32],[33], or to the microtubule associated motor protein kinesin (Nesprin 4) [34]. It may be the plectin cross-bridges between intermediate filaments and Nesprin 3 that were earlier observed as 5 to 6 nm short filaments by electron microscopy [27]. The binding of Nesprins to SUN proteins is necessary for effective force transmission between the nucleus and cytoskeleton [35].

We initially hypothesized that the changes in nuclear shape that were caused by reduction in BRG1 levels might arise from an altered balance of tensions at connections between the cytoskeleton and the nuclear lamina, changes downstream of altered expression of cytoskeleton or LINC complex proteins. In order to directly test this hypothesis, we disrupted microtubules, actin filaments, or cytokeratin filaments in MCF-10A cells engineered with a doxycycline inducible knockdown of BRG1. Even after each cytoskeletal disruption, nuclear profiles were significantly altered by the reduction in BRG1 protein levels. We conclude that the BRG1 related changes in the architecture of the nuclear lamina, nuclear envelope, and peripheral heterochromatin are not caused by altered tension exerted on the nucleus by the cytoskeleton, but rather from BRG1-related changes in internal nuclear forces.

Materials And Methods

Cell Culture

MCF-10A cells were obtained from the Karmanos Cancer Center (Detroit, Michigan). MCF-10A and MCF-10A derived cells were cultured in phenol red free DMEM/F12 media supplemented with cholera toxin, epidermal growth factor, insulin, and hydrocortisone as described [8],[36]. MDA-MB-231 [37],[38] and MDA-MB-231 derived cells were cultured in DMEM containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA). Knockdown was induced by addition of 10 ng/µl doxycycline (Sigma-Aldrich, St. Louis, MO).

Vectors, Lentivirus Production, And Generation Of Cell Lines

Vector generation, lentivirus production, and transduction of cells were described [8]. Briefly, MCF-10A or MDA-MB-231 cells were transduced with a lentivirus expressing the tTR-KRAB repressor and ds-Red fluorescent protein and fluorescence activated cell sorting (FACS) sorted to capture the ds-Red expressing population of cells. These cells were subsequently transduced with a doxycycline-inducible vector (PLVTHM; Addgene, Cambridge, MA) expressing a non-specific shRNA or a shRNA against either BRG1 or BRM [8] and green fluorescent protein (GFP). FACS sorting captured the ds-Red and GFP expressing cells, which were then verified for BRG1 or BRM knockdown by western blot. Virus was produced using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) in 293T cells.

Sirna Analysis In Mcf-10a Cells

MCF-10A cells were independently transfected with one of three siRNAs to BRG1 (Invitrogen #1-216547A01, #2-216547A05, #3-21547A03) using Lipofectamine 2000 following the manufacturer’s instructions. A control scrambled siRNA was used (Thermo Scientific Dharmacon - 21 base pair sequence AACAGUCGCGUUUGCGACUGG). Transfection efficiency was monitored with a Santa Cruz control siRNA (fluorescein conjugate)-A (sc-36869). The transfections were done in duplicate. Media was changed 6 hours after transfection and cells were harvested after 72 hours for Western blots and fixed for immunofluorescence.

Western Blot Analysis

Whole cell extracts from MCF-10A derived cells were prepared as described [8] from cells grown in the presence or absence of doxycycline for 3 days. The supernatant was separated by SDS-PAGE, and then transferred to nitrocellulose. MDA-MB-231 derived cells were lysed in 1× PBS containing 1% NP-40, 10 mM DTT, protease and phosphatase inhibitors cocktail (Roche, Indianapolis, IN) for 30 min at 4°C. Whole cell lysate was separated on a 4–20% SDS-PAGE (BioRad, Hercules, CA), and transferred to a PVDF membrane. Primary antibodies used were BRG1 (1∶1000, de la Serna et al, 2000), HP1γ (1∶500, Cell Signaling, Danvers, MA, 2619), PI3Kinase p85, H-SH2 domain (1∶1000, Millipore, Billerica, MA 06-496), GAPDH (1∶50000, Sigma-Aldrich, St. Louis, MO, G9295), and BRM (1∶1000; Abcam, Cambridge, MA, ab15597). GelQuant.NET software provided by biochemlabsolutions.com was used to quantify Western blots.

Papanicolaou Staining And Immunofluorescence

Papanicolaou stain was used to analyze the cell morphology of the MCF-10A and MCF-10A derived cell lines according to the classical method previously described [39]. Cells were grown on cover slips in 6-well dishes, and after induction with doxycycline for 6 days, were washed once with PBS, and then fixed by a direct immersion in 95% ethanol. Cells were stained successively with Haematoxylin for 60 seconds, Orange G for 30 seconds, and Eosin Azure for 2 minutes. Cells were rinsed with ethanol between each staining and given a final rinse with Xylene before mounting. Analyses were performed with a Zeiss Axoplan optical microscope.

Cytoskeletal Filament Disruption

Cells were treated with Latrunculin B (EDM Chemicals, Newark, NJ - 428020) at 0.2 µg/ml for 30 minutes, with Colcemid (CalbioChem, San Diego, CA –234109) at 0.05 µg/ml for 3 hours, or with sodium orthovanadate (Sigma-Aldrich, Saint Louis, MO – S6508) at 0.2 µg/ml for 30 minutes. Treated cells were then permeabilized for 10 minutes, ensuring the loss of constitutive dsRed and GFP, and then fixed following previously published methods [40].

Immunofluorescence

For immunofluorescence studies, the primary antibodies used were against α-Tubulin (1∶400, Sigma-Aldrich, St. Louis, MO, T-5168), Cytokeratin 18 (1∶50, Thermo-Scientific, Waltham, MA, MS-142), swine Lamin A/C clone 638 (1∶100, Gene Tex, Irvine CA, GTX72069), HP1γ(1∶1000, Millipore, Billerica, MA, MAB3450), Lamin B (1∶500, Millipore, Billerica, MA, Clone 101-B7, Cytokeratin 8 (1∶50, Abcam, ab2531), Emerin (1∶50, Santa Cruz Biotechnology,sc-15378), NuMA (1∶40, Millipore, Billerica, MA, 204-41), phospho-Histone H3 (Ser10),(1∶1000, Millipore, Billerica, MA, 05-598), Histone H1,(1∶100, Millipore, Billerica, MA, P10412), Histone H3 (1∶100, Abcam, Cambridge, UK, ab8580), Nesprin 1(1∶50, Abcam, Cambridge, MA ab5250), Nurim (1∶50, Santa Cruz Biotechnology, Santa Cruz, CA, sc-133262) H3K9 trimethylated (1∶100, Millipore, Billerica, MA, 17625), SRm160 splicing factor clone B1C8 (1∶100, Millipore, Billerica, MA), HMGN2 (1∶100, Millipore, Billerica, MA, 07252), Paxillin (1∶100, BD Biosciences, San Jose, CA, P13520/L16), Vimentin (1∶200, Sigma-Aldrich, St. Louis, MO,V-5255), and PML (1∶500, Millipore, Billerica, MA, AB1370). Appropriate secondary antibodies (GAR-IgG-488, GAR-IgG-568, GAM-IgG-488, GAM-IgG-568) were from Molecular Probes (Eugene, OR) and used at 1∶2000. Nuclei were counter stained with DAPI (4′, 6-diamidino-2-phenylindole) (1∶4000 to 1∶6000, Invitrogen, Carlsbad, CA, D3571) and DRAQ 5 (1∶2000 to 1∶4000, BioStatus Limited, Leicestershire, UK, DR50050). Actin filaments were detected with Phalloidin-TRITC (1∶1000, Sigma-Aldrich, St. Louis, MO, P-1951). Cells were scored and micrographs were taken using a Zeiss Axoplan optical microscope or a Leica laser scanning confocal microscope (SP1 or SP5-II AOBS).

Quantification And Statistical Analysis

A minimum of 200 and a maximum of 1000 nuclei were scored for each condition. Means plus or minus standard deviations are reported. Analysis of variance was determined with a Student’s t-test.

Electron Microscopy

Electron microscopy was performed as described [41]. MCF-10A cells were grown on Thermanox coverslips at 37°C as described above. Cells were then fixed in 2.5% glutaraldehyde in either 0.1 M sodium cacodylate or Sorensen’s phosphate buffer, pH 7.4 for 1 hour at 4°C, followed by an additional 1–2 hours at room temperature. Samples were post-fixed in 1% osmium in the same buffer as the fix at 4°C for 1 hour, washed, dehydrated in graded ethanol’s, and embedded in Epon with propyleneoxide as the transitional solvent. Some blocks were re-embedded at 90 degrees to the growth surface so that transverse sections could be prepared and imaged. Images were taken with a Philips CM10 transmission electron microscope with an image intensified CCD camera.

Results

Identification Of Brg1-Dependent Nuclear Structure

MCF-10A cells inducibly expressing a non-specific shRNA or shRNA against BRG1 or BRM (BRG1i and BRMi) have been previously described [8]. Western analysis for BRG1 and BRM expression confirmed the alteration in expression of these proteins (Figure 1A). Papanicolaou (PAP) staining is a multi-chromatic cell staining technique used in clinical cytology [39],[42],[43]. The many different colors and combinations of colors highlight many different features of cell architecture from chromatin condensation to cytokeratin expression. PAP staining of MCF-10A cells with inducible reduction of BRG1 levels identified many cells with altered nuclear shape, though there did not appear to be any significant changes in overall cell shape or size, or nuclear size. Irregularly shaped nuclei had clear and quantifiable features including curves and bulges that deviated from an oval profile and folds or invaginations in the structures of the nuclear surface. Some were lobulated sufficiently to have a kidney shape (Figure 1B). In contrast, oval shaped nuclei were consistently observed in the uninduced cells with normal levels of BRG1 (Figure 1B) as well as in both uninduced and induced cells expressing a scrambled sequence shRNA or the shRNA against BRM (data not shown). About one-third of the nuclei in the BRG1 knockdown cells were irregularly shaped, while ∼5% of the control cells showed an irregular nuclear appearance (Figure 1C). Less than 10% of the nuclei in the scramble control and BRM knockdown cells were irregular in shape, and the percentage of cells with irregular nuclei did not change in the presence of doxycycline. The results indicate that BRG1, but not BRM, plays a role in maintaining the normal nuclear shape.

thumbnail
Figure 1. BRG1 knockdown in MCF-10A cells increases the frequency of irregularly shaped nuclei.

(A) Western blot measuring the extent of BRG1 and BRM knockdown. PI3 Kinase was measured as a loading control. Induction of BRG1 or BRM knockdown correlates with Doxycycline (DOX) dependent GFP expression. (B) Representative images of irregular and regular shaped nuclei in PAP stained cells. Size bar 50 µm. (C) Quantification of irregularly shaped nuclei in MCF-10A cells upon BRG1 or BRM knockdown. SCRAM represents the control cells expressing a scrambled sequence shRNA. Data represent the means of 6 counts totaling a minimum of 200 (SCRAM +/− DOX), 290 (BRG1i +/− DOX), or 325 (BRMi +/− DOX) cells scored per cell line +/− standard deviation. *** represents p<0.005 as determined by Student’s t-test.

https://doi.org/10.1371/journal.pone.0055628.g001

Brg1-Dependent Nuclear Grooves

Since the irregular features of nuclei in BRG1 knockdown cells suggested structural alterations in the nuclear periphery, we examined the morphology of the nuclear lamina. The nuclear lamina of higher eukaryotes is a tightly woven meshwork of filaments connected to the inner nuclear membrane. The lamina is constructed from Lamin B proteins joined, in differentiated cells, by Lamins A and C, which are alternatively spliced from the same gene [44],[45]. Confocal imaging of both Lamin A/C and Lamin B revealed intensely staining nuclear grooves (arrows) in the BRG1 knockdown cells at an elevated frequency compared to the control cells cultured in the absence of doxycycline (Figure 2A) without any apparent difference in nuclear size. In addition to the presence of grooves, the Lamin A/C and Lamin B staining also identified the presence of kidney-shaped nuclei, (arrow head) as well as nuclei with blebs (thick arrow). Enlarged images are shown in Figure 2B. Quantification of the Lamin B stained cells indicated that approximately 30% of the nuclei in the BRG1 knockdown cells had grooves as compared to approximately 10% of the nuclei in the control cells (Figure 2C). Quantification of Lamin A/C stained cells indicated that nearly half of the nuclei showed evidence of grooves upon BRG1 knockdown, however, the background also rose, ranging between 15–20%. Though the frequency of grooved nuclei in BRG1 knockdown cells varied depending on whether the cells were stained for Lamin B or Lamin A/C, the increase relative to background remained ∼3-fold (Figure 2C). This figure is largely consistent with the increase in frequency of abnormally shaped nuclei observed by PAP staining (Figure 1). We suggest that reduction of BRG1 protein levels in MCF-10A mammary epithelial cells induces a deformation in nuclear shape that can be visualized by any of the three methods utilized.

thumbnail
Figure 2. Increased incidence of nuclear grooves occurs in BRG1 knockdown MCF-10A cells.

(A) MFC-10A cells in the presence or absence of BRG1 knockdown are shown labeled with either Lamin A/C or Lamin B. Arrows indicate grooves. Thick arrows indicate nuclear blebs. Arrowheads indicate kidney shaped nuclei. Size bar 10 µm. (B) Representative individual confocal sections of nuclei with grooves labeled with either Lamin A/C (center panel) or Lamin B (right and left panels). Arrows indicate grooves. Size bars 5 µm. (C) Quantification of grooved nuclei in MCF-10A cells upon BRG1 knockdown as identified by Lamin A/C or Lamin B staining. Data represent ten counts of at least 100 nuclei scored for grooves with Lamin A/C and three counts of at least 100 nuclei scored for grooves with Lamin B. Both are reported as means +/− standard deviation. *** represents p<0.005 as determined by Student’s t-test.

https://doi.org/10.1371/journal.pone.0055628.g002

It is important to note that we observed no evidence for changes in Lamin A/C or Lamin B levels upon BRG1 knockdown (Figure 2A and data not shown), suggesting that the expression of the genes encoding these proteins is not altered by the decrease in BRG1. We also took a candidate approach to examine by immunofluorescence staining the levels and localization of Lamin associated proteins as well as other markers of nuclear structure. No discernable changes in the Lamin associated proteins, Emerin, Nesprin, and Nurim were observed, nor were any changes in the splicing speckle component SRm160, the nuclear matrix associated nuclear mitotic apparatus protein (NUMA), or the chromatin associated protein high molecular weight group protein N2 (data not shown). In addition, no changes in staining against H1 or the modified histones phospho-H3Ser10 and H3triMeK4 were noted (data not shown).

To confirm that the observed effects on nuclear shape were specifically due to a reduction in BRG1 levels, we introduced three different siRNAs targeting BRG1 or a control siRNA into MCF-10A cells. Western blot analysis indicated a greater than 90% reduction in BRG1 protein levels following transfection of each of the BRG1-specific siRNAs (Figure 3A). We then evaluated the transfected cells for changes in nuclear shape. Confocal imaging of Lamin A/C confirmed the presence of nuclear grooves (arrows) (Figure 3B). Quantification indicated that 30% to 60% of the nuclei in cells with siRNA targeting BRG1had grooves, compared to 5% to7% in the untransfected and control scrambled siRNA cells (Figure 3C). This further confirms the observation that a reduction of BRG1 protein levels in MCF-10A cells induces nuclear shape changes.

thumbnail
Figure 3. siRNA targeting of BRG1 confirms changes in nuclear shape in MCF-10A cells.

(A) Western blot analysis of MCF-10A cells transfected with three different siRNAs that target BRG1 or a control siRNA. U represents untransfected MCF-10A cells. S represents the control cells expressing a scrambled siRNA. 1, 2, and 3 represent the three siRNAs targeting BRG1. PI3 Kinase was measured as a loading control. (B) Untransfected MCF-10A cells, control MCF-10A cells transfected with a scrambled siRNA, and MCF-10A cells transfected with three different siRNAs targeting BRG1 were labeled with Lamin A/C. Arrows indicate grooves. Size bars 10 µm. (C) Quantification of grooved nuclei in untransfected, control, and BRG1 siRNA treated cells. Data represent at least three independent counts of at least 100 nuclei scored for grooves. Results are reported as means +/− standard deviation. *** represents p<0.005 as determined by Student’s t-test whether the BRG1 knockdown results were compared to untransfected or to control siRNA treated cells.

https://doi.org/10.1371/journal.pone.0055628.g003

Nuclear Structure Is Brg1 Independent In Metastatic Breast Cells

The MDA-MB-231 cell line was derived from a metastatic breast adenocarcinoma [38]. Its karyotype is near-triploid but the chromosome content is heterogeneous in the population of cells. MDA-MB-231 cell nuclei are frequently irregularly shaped. MDA-MB-231 cells inducibly expressing shRNA against BRG1 (BRG1i) or a control shRNA (SCRAM) were engineered using the same methodology used to make the MCF-10A cells expressing shRNA targeting BRG1 (manuscript in preparation; see methods). To determine whether BRG1 affected nuclear structure in the context of this metastatic breast cancer cell line, we examined nuclei by Lamin A/C and Lamin B staining (Figure 4A–B). Oval shaped nuclei lacking the lobes, blebs, folds, or grooves previously described were considered “normal”, but such nuclei were observed in, at most, 5% of cells, and in most cases, the percentage of regularly shaped nuclei was much lower (Figure 4C–D). Most nuclei were characterized by prominent grooves, irregular shapes, and/or multiple lobes (Figure 4A–B). Quantification of the number of nuclei containing grooves or multi-lobed nuclei indicated that about one-third contained grooves and approximately two-thirds were multi-lobed. Reduction of BRG1 levels had no effect on the relative proportion of nuclear alterations (Figure 4C–D). Western blot analysis confirmed the inducible knockdown of BRG1 in these cells (Figure 4E). The Catalogue of Somatic Mutations in Cancer (COSMIC) Cell Line Project database indicates that the gene encoding BRG1 is not mutated in MDA-MB-231 cells (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/). We conclude that reduction of BRG1 in the context of a metastatic breast cancer cell that already shows altered nuclear morphology has no additional effect on nuclear structure.

thumbnail
Figure 4. The frequency of grooved and multi-lobed nuclei in MDA-MB-231 cells is independent of BRG1.

(A, B) Multiple representative individual confocal sections of MDA-MB-231 cells with and without BRG1 knockdown are shown labeled with either Lamin A/C (A) or Lamin B (B). SCRAM represents the control cells expressing a scrambled sequence shRNA. Nuclei were counterstained with the DNA dye DRAQ5. Arrows indicate nuclear grooves. Thick arrows indicate multi-lobed nuclei. Size bars 10 µm. (C, D) Quantification of regular, grooved, and multi-lobed nuclei indicated no change in MDA-MB-231 cells with or without BRG1 knockdown as determined by staining with Lamin A/C (C) or Lamin B (D). Data represent three counts of at least 100 nuclei scored for grooves under each condition and are reported as the means +/− standard deviation. (E) Western blot analysis of BRG1 levels. GAPDH levels were monitored as a loading control.

https://doi.org/10.1371/journal.pone.0055628.g004

Detailed Examination Of Nuclear Structure

Next, we determined whether there was any spatial relationship between the nuclear grooves and peripheral heterochromatin. Immunofluorescent staining of heterochromatin protein 1 (HP1) indicated that heterochromatin distribution in these cells was not altered by BRG1 knockdown and that there was no preferential localization between HP1 and the nuclear grooves (arrows) (Figure 5A). Despite the lack of any obvious connection between HP1 and BRG1-dependent nuclear grooves, Western blot analysis indicated that cells expressing the BRG1 shRNA contained a slight reduction in HP1 protein levels (Figure 5B).

thumbnail
Figure 5. HP1 is not concentrated in nuclear grooves induced by knockdown of BRG1 in MCF-10A cells.

(A) Representative and matched individual confocal sections of Lamin B (green) and HP1 (red) stained cells grown in the presence or absence of doxycycline. Nuclei were counterstained with the DNA dye DRAQ5 (blue). Arrows indicate grooves in the Lamin B and Overlay images. Arrows indicate lack of corresponding grooves in the HP1 image. Size bar 10 µm. (B) Western blot analysis of HP1 and BRG1 levels. GAPDH levels were measured as a loading control.

https://doi.org/10.1371/journal.pone.0055628.g005

Electron microscopy was used to evaluate the ultrastructure of MCF-10A nuclei after BRG1 knockdown. Sections were prepared in two orientations: parallel to the growth surface and perpendicular to the growth surface. The latter permitted an evaluation of nuclear shape changes at the apical and basal surfaces of the nucleus. This was especially important because the folds in the nuclear lamina that we observed were often on the basal, or top, surface of the nucleus. MCF-10A cells [41] or uninduced MCF-10A BRG1i cells (Figure 6A and G) had regular oval shapes when viewed in either orientation. BRG1 knockdown caused an increase in irregularities in the structures of the nuclear periphery. In sections perpendicular to the growth surface, nuclear shape changes included irregularities in shape and deviations from an oval profile (Figs. 6B and C), and grooves at the top surface of nuclei (Figs. 6C, D, E, and F). Figure 6E presents a higher magnification view of the groove in the nucleus of Figure 6C, while Figure 6F presents a higher magnification view of the groove in the nucleus of Figure 6D (see arrow). In the larger groove of Figure 6E, five nuclear pores are visible, showing that this section is taken near the side wall of the groove, where a more regular profile is resumed. When imaged in sections parallel to the growth surface (Figure 6H), many nuclei had deep lateral invaginations of the nuclear lamina and envelope into the nuclear interior (see arrow). These were deeper than the grooves at the apical surface of the nucleus and sometimes terminated at or near nucleoli. These lateral invaginations were, on average, wider in diameter than the nucleoplasmic reticulum structures reported to connect with nucleoli [46],[47], though we cannot rule out a relationship between the two structures. The invaginations induced by BRG1 knockdown did resemble the nuclear invaginations that we have reported in three dimensional reconstituted basement membrane cultures of MCF-10A cells [41].

thumbnail
Figure 6. The Ultrastructure of MCF-10A cells with BRG1 knockdown.

Sections were prepared for electron microscopy in two orientations: perpendicular to the growth surface (panels A to F) and parallel to the growth surface (panels G and H). Representative images of the structures quantified in Figures 1 and 2 are shown. (A) Uninduced control MCF-10A BRG1i cells had regular oval profiles when viewed perpendicular to the growth plane. For all cells shown in this orientation, the basal side of the cell adjacent to the growth surface is toward the bottom of the micrograph, while the apical surface is facing up. (B) Irregular contours were induced in cells after BRG1 knockdown. (C) After BRG1 knockdown, some nuclei developed both irregular contours and grooves in the apical surface of the nuclei. The groove in this nucleus is shown at higher magnification in panel E. (D) Other nuclei had grooves on their apical sides but a more normal nuclear contour. Arrow indicates groove. The groove for this nucleus is shown at higher magnification in panel F. (E) Higher magnification view of the groove in the nucleus of panel C. Five nuclear pores are visible in the cleft of the groove. This shows that the wall of the groove is in an adjacent plane of section. (F) Higher magnification view of the groove in the nucleus of panel D. (G) Uninduced control MCF-10A BRG1i cells had regular oval profiles when viewed parallel to the growth plane. (H) After induction of BRG1 knockdown, these nuclei sometimes had deep invaginations of the nuclear lamina and covering envelope that projected deep into the nuclear interiors and sometimes terminated adjacent to nucleoli. Arrow indicates groove. Size bar panel E 0.5 µm. All other size bars are 2 µm.

https://doi.org/10.1371/journal.pone.0055628.g006

Evaluation Of Nuclear-Cytoplasmic Contacts

The nucleus is connected to the cytoskeleton through direct and indirect contacts with actin filaments, microtubules, and intermediate filaments [18],[21][24],[27][29]. These contacts keep the nucleus under isometric tension and are expected to be a major determinant of nuclear shape [19],[20],[35]. We hypothesized that altered and unequal tension applied to the nucleus through the cytoskeleton could cause the BRG1 knockdown-induced changes in nuclear profile. Therefore, disruption of the cytoskeleton may suppress nuclear profile changes in BRG1-knockdown cells.

Latrunculins are a family of natural products and toxins produced by sponges of the family latrunculia [48]. Latrunculin B binds ß-Actin, preventing polymerization and, when added to cells, it depolymerizes actin filaments [49],[50]. It has specifically been shown to disrupt the actin cytoskeleton in MCF10A cells [51]. Figure 7A shows ß-Actin staining in control cells cultured in the absence of doxycycline and in the presence or absence of Latrunculin B. In the untreated cells, long continuous actin fibers were observed throughout the cytoplasm. In treated cells the actin fibers were clearly disrupted (Figure 7A). Latrunculin B treatment did not, however, alter the percentage of cells showing nuclear grooves in either the presence or absence of BRG1 knockdown (Figure 7B).

thumbnail
Figure 7. Induction of nuclear grooves after knockdown of BRG1 does not depend on intact actin filaments.

(A) Matched individual confocal sections of representative fields of cells before and after treatment with Latrunculin B at 0.2 µg/ml for 30 minutes. Actin filaments were detected with Phalloidin-TRITC (red), while nuclei were counterstained with the DNA dye DRAQ5 (blue). Size bar 10 µm. (B) Quantification of nuclear grooves in control cells and cells treated with Latrunculin B. The means for three counts of at least 100 nuclei scored for grooves under each condition are presented +/− standard deviation. * represents p<0.05, *** represents p<0.005 as determined by Student’s t-test.

https://doi.org/10.1371/journal.pone.0055628.g007

Colcemid depolymerizes microtubules and prevents new microtubule polymerization [52],[53]. Microtubules seen in untreated cells were almost completely disrupted by colcemid treatment (Figure 8A). Colcemid treatment to disrupt microtubules did not change the frequency of grooves upon BRG1 knockdown (Figure 8B).

thumbnail
Figure 8. Induction of nuclear grooves after knockdown of BRG1 does not depend on intact microtubules.

(A) Matched individual confocal sections of representative fields of cells before and after treatment with Colcemid at 0.05 µg/ml for 3 hours. Microtubules were detected with an α-Tubulin antibody (green), while nuclei were counterstained with the DNA dye DRAQ5 (blue). Size bar 10 µm. (B) Quantification of nuclear grooves in cells treated with Colcemid. The means for three counts of at least 100 nuclei scored for grooves under each condition are presented +/− standard deviation. * represents p<0.05, *** represents p<0.005 as determined by Student’s t-test.

https://doi.org/10.1371/journal.pone.0055628.g008

The nucleus is also connected to intermediate filaments, which in epithelial cells such as MCF-10A are heteropolymers of cytokeratins. Sodium orthovanadate is a tyrosine phosphatase inhibitor [54] that has been shown to induce transient and reversible alterations in the cytokeratin filament network [55]. Orthovanadate treatment of cells disrupted both intermediate filaments (Figure 9A-α-Tubulin) and actin filament organization (Figure 9A-Phalloidin) and induced a rearrangement of the microtubule network (Figure 9A–CK18). While orthovanadate treatment caused a slight increase in the percentage of cells in the population containing nuclear grooves, the increase occurred both in the presence and absence of BRG1 knockdown. Differences between untreated and treated cells were not statistically significant, and the ratio of cells containing grooves in BRG1 knockdown cells to control cells was unchanged after orthovanadate treatment (Figure 9B). We conclude that disruption of the major cytoskeletal filament systems in mammary epithelial cells does not mediate BRG1-dependent structural alterations in the nuclear periphery.

thumbnail
Figure 9. Induction of nuclear grooves after BRG1 knockdown is unaffected by disruption of the cytokeratin network.

(A) Matched individual confocal sections of representative fields of cells before and after treatment with orthovanadate at 0.2 µg/ml for 30 minutes. Microtubules, actin filaments, and cytokeratin filaments were detected with an α-Tubulin antibody (left column), Phalloidin-TRITC (center column), and with a Cytokeratin 18 (CK18) antibody (right column), respectively. Nuclei were counterstained with the DNA dye DRAQ5 (blue). Size bars 10 µm. (B) Quantification of nuclear grooves in cells treated with orthovanadate. The means for three counts of at least 100 nuclei scored for grooves under each condition are presented +/− standard deviation. *** represents p<0.005 as determined by Student’s t-test.

https://doi.org/10.1371/journal.pone.0055628.g009

Discussion

The Role Of Brg1 In Regulating Nuclear Shape

BRG1 and BRM are the alternative ATPase subunits for SWI/SNF chromatin remodeling enzymes [56]. Depletion of either BRG1 or BRM causes a slow growth phenotype in non-tumorigenic MCF-10A mammary epithelial cells [8]. We report here that depletion of BRG1, but not of BRM, induced nuclear shape changes in MCF-10A cells. These changes in nuclear shape included folding in the structures at the nuclear periphery, the nuclear lamina and envelope, and lobulation. Similar changes have been observed in patients with laminopathies, diseases caused by the mutation of Lamin A or its interacting structural proteins [15],[16].

The determinants of nuclear shape are poorly understood. The nucleus in differentiated cells is under tension mediated by a pre-stressed cytoskeleton [19],[57]. The balance of forces delivered to the nucleus in this way may account for the great variety of nuclear shapes observed in tissues.

In this report, we tested the hypothesis that changes in nuclear shape that follow BRG1 reduction are mediated by nuclear tension. This hypothesis was consistent with published work on nuclear-cytoskeletal connections and also with an intriguing literature on the connections between BRG1 and the control of cell size and shape. Re-introduction of BRG1 into BRG1 deficient adenocarcinoma cell lines not only induced cell cycle arrest but also caused the cells to assume a flatter and larger appearance with an increased area of surface attachment [58][61]. BRG1 deficient adenocarcinoma cells expressing an ATPase defective BRG1 induced a “flat cell” phenotype at a significantly reduced frequency [58],[61], suggesting that the change in cell morphology required BRG1 enzymatic activity. The observed morphology change was attributed to BRG1-dependent organization of actin filaments [60]. However other studies employing inducible expression of the same ATPase-deficient BRG1 allele in NIH3T3-derived mouse fibroblasts reported a similar “flat cell” morphology that involved altered focal adhesions but apparently normal actin organization [62]. Thus there are likely multiple mechanisms by which BRG1 controls cell morphology. These previous results are all consistent with the hypothesis that BRG1-related changes in the cytoskeleton also may cause changes in nuclear morphology. This idea is further supported by the observation that interference with SWI/SNF enzyme function via expression of a dominant negative, ATPase-deficient BRG1 resulted in increased nuclear size [62].

Despite the attractiveness of the working hypothesis, the results were inconsistent, suggesting that internal nuclear mechanisms are responsible for BRG1-mediated shape changes. The concept that epigenetic regulators might help maintain the structural integrity of nuclei is appealing because most of these proteins and complexes have the capacity to alter chromatin structure and because chromatin is mechanically coupled to the nuclear lamina. Chromatin modifying proteins that post-translationally add or remove methyl, acetyl, phospho, ubiquitin, or ADP-ribose groups, among others, have an obvious potential to locally, and perhaps globally, affect chromatin structure and organization [63]. ATP-dependent chromatin remodeling enzymes have the capacity to exert force. Some of this force is used to reorganize chromatin structure by breaking histone:DNA contacts to allow nucleosome movement along DNA, histone displacement, and/or replacement of histones with variant histone counterparts [3]. SWI/SNF enzymes are the prototype ATP-dependent chromatin remodelers in higher eukaryotes; these enzymes have been shown to alter chromatin structure both locally, as demonstrated by changes in chromatin accessibility at target gene regulatory sequences, as well as at a distance, as shown by a dependence on the ATPase subunit BRG1 for intra-chromosomal looping and inter-chromosomal interactions [64][67]. BRG1 also contributes to gene expression and may also indirectly affect chromatin and nuclear structure by altering the levels of chromatin components, such as the modest changes in HP1 levels that were observed (Figure 5B). Additional studies will be needed to address the possibility that the induced changes in nuclear structure are due to forces internal to the nucleus caused by changes in chromatin organization.

Nuclear Shape Changes And Connections To Cancer

Nuclear surface folds and lobulation have been observed in cancer, including breast tumors where alterations in nuclear structure are important diagnostic and prognostic markers [12][14]. Despite the dependence of cancer diagnostics on microscopic evaluation of patient biopsies, our understanding of the molecular basis for these cellular structural changes is rather poor. In particular, the molecular mechanisms underlying these changes in nuclear structure remain enigmatic. Although not explained in molecular detail, changes in the shape of nuclei in tumors have been observed since the 1860′s [68]. Irregular nuclear contours in tumor cells often correlate with altered spatial organization of chromatin [12]. Diagnostically useful nuclear features include lobulation, the development of grooves, clefts, or folds, changes in nuclear size, alterations in heterochromatin organization and increases or decreases in the number or appearance of nucleoli. The set of nuclear alterations observed clinically is characteristic of particular tumor types, and not shared by all tumors. The degree of nuclear contour irregularity observed in breast tumors correlates with loss of progesterone receptor expression and with disease progression [13]. Nuclear contour irregularities also predict disease relapse in node negative breast cancer patients [14].

Here we demonstrate that the BRG1 ATPase of an ATP dependent chromatin remodeling enzyme has the capability of regulating nuclear shape. Intriguingly, there are numerous connections between BRG1 and cancer. BRG1 deficient mice are early-embryonic lethal but ∼10% of BRG1 heterozygous mice present with mammary tumors [9],[11]. Primary human breast, lung, pancreas, colon, and prostate tumor samples and/or cell lines derived from such tumors have been reported to contain BRG1 alleles that are deleted, mutated or silenced (reviewed in [69],[70]), further supporting the idea that BRG1 functions as a tumor suppressor. However, other reports indicate that BRG1 expression is elevated in primary tumors and that BRG1 knockdown reduces cell proliferation [71][76]. The correlation between inhibition of cell proliferation and BRG1 extends to non-transformed cells as well [8],[77]. Thus the requirement for BRG1 in cellular proliferation and cell transformation is complex and may be context-dependent.

Similarly, the relationship between BRG1 and control of nuclear shape is likely complex and may be context-dependent. BRG1 knockdown in immortalized but non-transformed mammary epithelial cells induces nuclear structural changes reminiscent of changes seen in tumors (Figures 1 and 2) yet was shown to decrease cell proliferation [8]. BRG1 may therefore control the delicate balance between hypo- and hyper-proliferative states. However, there may be limits to the ability of BRG1 to maintain this balance. The MDA-MB-231 cells generated from a metastasized and drug-resistant breast tumor [38] had extremely distorted nuclear profiles, and we did not see significant further alterations after BRG1 reduction (Figure 4). While it may be that BRG1 effects on nuclear shape are lost after malignant transformation, it is also possible that the perturbation of nuclear architecture in MDA-MB-231 cells is already so severe that subtle additional changes could not be distinguished.

Summary

We have shown that BRG1-dependent changes in nuclear structure do not involve cytoskeletal tension mediated through nuclear-cytoskeletal contacts. We propose that instead, alterations in nuclear structure are generated from within the nucleus as a result of deficiencies in normal chromatin remodeling and organization by BRG1. Our results have implications in understanding the mechanisms involved in nuclear shape changes in diseases such as laminopathies and cancer [12],[15],[16] as well as in development [57],[78].

Author Contributions

Conceived and designed the experiments: KMI ANI JAN. Performed the experiments: KMI NC QW JMU. Analyzed the data: KMI NC QW JMU ANI JAN. Wrote the paper: KMI ANI JAN.

References

  1. 1. Imbalzano AN, Kwon H, Green MR, Kingston RE (1994) Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature 370: 481–485.
  2. 2. Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR (1994) Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature 370: 477–481.
  3. 3. Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78: 273–304.
  4. 4. Liu R, Jiang B, Yu H, Chaput JC (2011) Generating DNA synbodies from previously discovered peptides. Chembiochem 12: 1813–1817.
  5. 5. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR (1993) BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366: 170–174.
  6. 6. Muchardt C, Yaniv M (1993) A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. Embo J 12: 4279–4290.
  7. 7. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, et al. (1996) Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10: 2117–2130.
  8. 8. Cohet N, Stewart KM, Mudhasani R, Asirvatham AJ, Mallappa C, et al. (2010) SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells. J Cell Physiol 223: 667–678.
  9. 9. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, et al. (2008) Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 27: 460–468.
  10. 10. Serber DW, Rogala A, Makarem M, Rosson GB, Simin K, et al. (2012) The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner. PLoS One 7: e31346.
  11. 11. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, et al. (2000) A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6: 1287–1295.
  12. 12. Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4: 677–687.
  13. 13. Haroske G, Dimmer V, Friedrich K, Meyer W, Thieme B, et al. (1996) Nuclear image analysis of immunohistochemically stained cells in breast carcinomas. Histochem Cell Biol 105: 479–485.
  14. 14. Giardina C, Renzulli G, Serio G, Caniglia DM, Lettini T, et al. (1996) Nuclear morphometry in node-negative breast carcinoma. Anal Quant Cytol Histol 18: 374–382.
  15. 15. Capell BC, Collins FS (2006) Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 7: 940–952.
  16. 16. Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226: 316–325.
  17. 17. Bank EM, Gruenbaum Y (2011) The nuclear lamina and heterochromatin: a complex relationship. Biochem Soc Trans 39: 1705–1709.
  18. 18. Maniotis AJ, Chen CS, Ingber DE (1997) Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A 94: 849–854.
  19. 19. Wang N, Tytell JD, Ingber DE (2009) Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol 10: 75–82.
  20. 20. Mazumder A, Roopa T, Kumar A, Iyer KV, Ramdas NM, et al. (2010) Prestressed nuclear organization in living cells. Methods Cell Biol 98: 221–239.
  21. 21. Franke WW (1971) Relationship of nuclear membranes with filaments and microtubules. Protoplasma 73: 263–292.
  22. 22. Capco DG, Wan KM, Penman S (1982) The nuclear matrix: three-dimensional architecture and protein composition. Cell 29: 847–858.
  23. 23. Jones JC, Goldman AE, Steinert PM, Yuspa S, Goldman RD (1982) Dynamic aspects of the supramolecular organization of intermediate filament networks in cultured epidermal cells. Cell Motil 2: 197–213.
  24. 24. Fey EG, Capco DG, Krochmalnic G, Penman S (1984) Epithelial structure revealed by chemical dissection and unembedded electron microscopy. J Cell Biol 99: 203s–208s.
  25. 25. Vikstrom KL, Borisy GG, Goldman RD (1989) Dynamic aspects of intermediate filament networks in BHK-21 cells. Proc Natl Acad Sci U S A 86: 549–553.
  26. 26. Djabali K, Portier MM, Gros F, Blobel G, Georgatos SD (1991) Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell 64: 109–121.
  27. 27. Carmo-Fonseca M, Cidadao AJ, David-Ferreira JF (1988) Filamentous cross-bridges link intermediate filaments to the nuclear pore complexes. Eur J Cell Biol 45: 282–290.
  28. 28. Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, et al. (2006) Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Bio 172: 41–53.
  29. 29. Starr DA, Fridolfsson HN (2010) Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges. Annu Rev Cell Dev Biol 26: 421–444.
  30. 30. Padmakumar VC, Abraham S, Braune S, Noegel AA, Tunggal B, et al. (2004) Enaptin, a giant actin-binding protein, is an element of the nuclear membrane and the actin cytoskeleton. Exp Cell Res 295: 330–339.
  31. 31. Zhen YY, Libotte T, Munck M, Noegel AA, Korenbaum E (2002) NUANCE, a giant protein connecting the nucleus and actin cytoskeleton. J Cell Sci 115: 3207–3222.
  32. 32. Ketema M, Wilhelmsen K, Kuikman I, Janssen H, Hodzic D, et al. (2007) Requirements for the localization of nesprin-3 at the nuclear envelope and its interaction with plectin. J Cell Sci 120: 3384–3394.
  33. 33. Wilhelmsen K, Litjens SH, Kuikman I, Tshimbalanga N, Janssen H, et al. (2005) Nesprin-3, a novel outer nuclear membrane protein, associates with the cytoskeletal linker protein plectin. J Cell Biol 171: 799–810.
  34. 34. Roux KJ, Crisp ML, Liu Q, Kim D, Kozlov S, et al. (2009) Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A 106: 2194–2199.
  35. 35. Lombardi ML, Jaalouk DE, Shanahan CM, Burke B, Roux KJ, et al. (2011) The interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton. J Biol Chem 286: 26743–26753.
  36. 36. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256–268.
  37. 37. Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, et al. (2005) Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A 102: 1454–1459.
  38. 38. Cailleau R, Olive M, Cruciger QV (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911–915.
  39. 39. Marshall PN (1983) Papanicolaou staining–a review. Microsc Acta 87: 233–243.
  40. 40. Wagner S, Chiosea S, Nickerson JA (2003) The spatial targeting and nuclear matrix binding domains of SRm160. Proc Natl Acad Sci U S A 100: 3269–3274.
  41. 41. Underwood JM, Imbalzano KM, Weaver VM, Fischer AH, Imbalzano AN, et al. (2006) The ultrastructure of MCF-10A acini. J Cell Physiol 208: 141–148.
  42. 42. Feoli F, Paesmans M, Van Eeckhout P (2008) Fine needle aspiration cytology of the breast: impact of experience on accuracy, using standardized cytologic criteria. Acta Cytol 52: 145–151.
  43. 43. Paesmans M (2008) [Stage IV NSCLC. Prognostic factors]. Rev Mal Respir 25: 3S99–106.
  44. 44. Shimi T, Butin-Israeli V, Adam SA, Goldman RD (2010) Nuclear lamins in cell regulation and disease. Cold Spring Harb Symp Quant Biol 75: 525–531.
  45. 45. Dittmer TA, Misteli T (2011) The lamin protein family. Genome Biol 12: 222.
  46. 46. Goulbourne CN, Malhas AN, Vaux DJ (2011) The induction of a nucleoplasmic reticulum by prelamin A accumulation requires CTP:phosphocholine cytidylyltransferase-alpha. J Cell Sci 124: 4253–4266.
  47. 47. Fricker M, Hollinshead M, White N, Vaux D (1997) Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Bio 136: 531–544.
  48. 48. Spector I, Shochet NR, Kashman Y, Groweiss A (1983) Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 219: 493–495.
  49. 49. Spector I, Shochet NR, Blasberger D, Kashman Y (1989) Latrunculins–novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Cell Motil Cytoskeleton. 13: 127–144.
  50. 50. Yarmola EG, Somasundaram T, Boring TA, Spector I, Bubb MR (2000) Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. J Biol Chem 275: 28120–28127.
  51. 51. Martin SS, Leder P (2001) Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol 21: 6529–6536.
  52. 52. Enomoto T (1996) Microtubule disruption induces the formation of actin stress fibers and focal adhesions in cultured cells: possible involvement of the rho signal cascade. Cell Struct Funct 21: 317–326.
  53. 53. Vasiliev JM, Gelfand IM, Domnina LV, Ivanova OY, Komm SG, et al. (1970) Effect of colcemid on the locomotory behaviour of fibroblasts. J Embryol Exp Morphol 24: 625–640.
  54. 54. Gordon JA (1991) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol 201: 477–482.
  55. 55. Strnad P, Windoffer R, Leube RE (2002) Induction of rapid and reversible cytokeratin filament network remodeling by inhibition of tyrosine phosphatases. J Cell Sci 115: 4133–4148.
  56. 56. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, et al. (1996) Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 15: 5370–5382.
  57. 57. Mazumder A, Shivashankar GV (2010) Emergence of a prestressed eukaryotic nucleus during cellular differentiation and development. J R Soc Interface 7 Suppl 3S321–330.
  58. 58. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, et al. (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119–130.
  59. 59. Strober BE, Dunaief JL, Guha, Goff SP (1996) Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 16: 1576–1583.
  60. 60. Asp P, Wihlborg M, Karlen M, Farrants AK (2002) Expression of BRG1, a human SWI/SNF component, affects the organisation of actin filaments through the RhoA signalling pathway. J Cell Sci 115: 2735–2746.
  61. 61. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E (1999) Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol Cell Biol 19: 1460–1469.
  62. 62. Hill DA, Chiosea S, Jamaluddin S, Roy K, Fischer AH, et al. (2004) Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme. J Cell Sci 117: 5847–5854.
  63. 63. Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21: 381–395.
  64. 64. Kim SI, Bresnick EH, Bultman SJ (2009) BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription. Nucleic Acids Res 37: 6019–6027.
  65. 65. Kim SI, Bultman SJ, Kiefer CM, Dean A, Bresnick EH (2009) BRG1 requirement for long-range interaction of a locus control region with a downstream promoter. Proc Natl Acad Sci U S A 106: 2259–2264.
  66. 66. Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt KR, et al. (2008) Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci U S A 105: 19199–19204.
  67. 67. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278–1288.
  68. 68. Beale LS (1860) Examination of sputum from a case of cancer of the pharynx and the adjacent parts. Archives of Medicine, London 2: 44.
  69. 69. Wu JI (2012) Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer. Acta Biochim Biophys Sin (Shanghai) 44: 54–69.
  70. 70. Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481–492.
  71. 71. Lin H, Wong RP, Martinka M, Li G (2010) BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol 163: 502–510.
  72. 72. Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, et al. (2007) Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 67: 203–213.
  73. 73. Heeboll S, Borre M, Ottosen PD, Andersen CL, Mansilla F, et al. (2008) SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. Histol Histopathol 23: 1069–1076.
  74. 74. Sentani K, Oue N, Kondo H, Kuraoka K, Motoshita J, et al. (2001) Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas. Pathobiology 69: 315–320.
  75. 75. Watanabe T, Semba S, Yokozaki H (2011) Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells. Br J Cancer 104: 146–154.
  76. 76. Saladi SV, Keenen B, Marathe HG, Qi H, Chin KV, et al. (2010) Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol Cancer 9: 280.
  77. 77. Bourgo RJ, Siddiqui H, Fox S, Solomon D, Sansam CG, et al. (2009) SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity. Mol Biol Cell 20: 3192–3199.
  78. 78. Webster M, Witkin KL, Cohen-Fix O (2009) Sizing up the nucleus: nuclear shape, size and nuclear-envelope assembly. J Cell Sci 122: 1477–1486.